Neurological & Cognitive
Depressive states↓45%
Anxious thoughts↓35%
Memory↑32%
Sleep quality↑31%
S2Y Strategy
World's Most Studied Solutions for Long Covid
S2Y uniquely combines medical-grade Hypochlorous Acid (HOCl) with transcutaneous Vagus Nerve Stimulation (tVNS).
This dual-action strategy addresses the two primary drivers of chronic post-viral conditions: viral persistence and inflammatory dysregulation.
The Dual-Action Advantage
Why tVNS + HOCl is the breakthrough for recovery
1. Pathogen Control (HOCl)
HOCl is the immune system's own weapon. We use medical-grade HOCl to safely target viral reservoirs in the oral and nasal cavities, reducing the pathogen load that drives chronic immune activation.
2. Autonomic Regulation (tVNS)
The vagus nerve is the body's "anti-inflammatory superhighway." tVNS non-invasively stimulates this pathway to reduce systemic inflammation (cytokine storms) and restore autonomic balance.
3. Synergistic Recovery
Targeting one cause isn't enough. By clearing the pathogen trigger (HOCl) while simultaneously calming the hyperactive immune response (tVNS), we create the optimal biological window for deep healing.
Inflammation Reduction
78% Reduction
Before
100%
After
22%
Mechanism of Action
How the S2Y Protocol addresses Long Covid
Step 1: Cleanse & Neutralize
Daily use of S2Y HOCl reduces surface pathogens and biofilm, preventing reinfection and lowering the total viral burden on the immune system.
Step 2: Calming the Storm (tVNS Evidence)
Analysis of 50+ studies shows tVNS reduces inflammation by 78% and improves Vagus Nerve Activity by 61%, directly activating the Cholinergic Anti-inflammatory Pathway.
78% inflammation reduction
61% improved VNA
Step 3: Restoring Homeostasis
Post-viral symptoms reduced by 61% and fatigue by 48%. The system shifts from "fight or flight" back to "rest and repair," alleviating brain fog and PEM.
61% symptom reduction
48% fatigue reduction
Quantified Methods & Outcomes
Based on 50+ scientific studies and 4M+ stimulation sessions with 0 serious adverse events in clinical trials.
Inflammation Reduced
78%
Reduction in inflammatory markers
Post-viral Symptoms
↓61%
Significant symptom improvement
Gut Symptoms
↓80%
Digestive health restoration
Fatigue Reduced
48%
Energy level improvement
Systemic Improvements
Measured benefits across critical physiological systems
Cardiovascular & Autonomic
HRV↑18%
Palpitations↓85%
POTS-related tachycardia↓40%
Microcirculation↑39%
Gut & Digestive
Gut symptoms↓80%
Post-viral symptoms↓61%
Fatigue↓48%
Join the Recovery Strategy
Evidence-based care for the post-pandemic era
Clinician Partnerships
Integrate the S2Y protocol into your practice for better patient outcomes.
Patient Access
Start your journey with our home-use kits and AI guidance.